Platinum-Montaur Life Sciences, LLC insider trades: Navidea Biopharmaceuticals (NAVB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Platinum-Montaur Life Sciences, LLC reports to the SEC
Open-market buys and sales
9 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2014 | NAVB | ↓ Sell | 60,000 | $1.36 | $82K | By Platinum Partners Value Arbitrage Fun | Sep 4, 2014 (2d) |
| Jun 30, 2014 | ECTE | ↑ Buy | 65,739 | $2.20 | $145K | By Platinum Partners Liquid Opportunity | Jul 1, 2014 (1d) |
| Jun 26, 2014 | ECTE | ↑ Buy | 17,300 | $2.20 | $38K | By Platinum Partners Liquid Opportunity | Jun 27, 2014 (1d) |
| Jun 24, 2014 | ECTE | ↑ Buy | 16,961 | $2.20 | $37K | By Platinum Partners Liquid Opportunity | Jun 24, 2014 (0d) |
| Dec 10, 2013 | ECTE | ↑ Buy | 55,655 | $2.75 | $153K | By Platinum Partners Value Arbitrage Fun | Dec 12, 2013 (2d) |
| Dec 10, 2013 | ECTE | ↑ Buy | 13,914 | $2.75 | $38K | By Platinum Partners Liquid Opportunity | Dec 12, 2013 (2d) |
| Oct 10, 2012 | NAVB | ↑ Buy | 37,030 | $2.56 | $95K | Direct | Nov 9, 2012 (30d) |
| Sep 21, 2012 | NAVB | ↓ Sell | 708,382 | $3.70 | $2.6M | Direct | Nov 9, 2012 (49d) |
| Sep 25, 2009 | DLYT.OB | ↓ Sell | 86,536 | $1.54 | $133K | Direct | Nov 4, 2009 (40d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Platinum-Montaur Life Sciences, LLC's insider trades
Platinum-Montaur Life Sciences, LLC is a 10% owner of Navidea Biopharmaceuticals (NAVB). Since Sep 25, 2009, it has reported 6 open-market purchases worth $506K and 3 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (4 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.